Free Trial

AlloVir (ALVR) SEC Filings & 10K Form

AlloVir logo
$3.33 +0.08 (+2.46%)
As of 05/20/2025

Recent AlloVir SEC Filings

DateFilerForm TypeView
05/15/2025
1:06 PM
EcoR1 Capital, LLC (Filed by)
AlloVir (Subject)
Form SCHEDULE 13G/A
05/14/2025
7:09 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
3:18 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2025
4:04 PM
AlloVir (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:08 PM
Jovan-Embiricos Morana (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:20 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:27 PM
Hagen Brett R (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:03 PM
Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:41 PM
Hallal David (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
7:21 AM
AlloVir (Issuer)
PATTERSON LEONE D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2025
7:12 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
6:19 PM
Hagen Brett R (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:06 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 3/A
03/25/2025
6:38 PM
AlloVir (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2025
6:40 PM
AlloVir (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SCHEDULE 13D
03/20/2025
3:32 PM
GILEAD SCIENCES, INC. (Filed by)
AlloVir (Subject)
Form SCHEDULE 13G/A
03/18/2025
4:44 PM
AlloVir (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:45 PM
Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:37 PM
ADAMIS ANTHONY P (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:40 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:41 PM
AlloVir (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:43 PM
Feinsod Matthew (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:25 PM
Dybbs Michael (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:27 PM
Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:30 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:14 PM
ADAMIS ANTHONY P (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:17 PM
Feinsod Matthew (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:20 PM
AlloVir (Issuer)
Oxtoby Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:21 PM
AlloVir (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:04 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:18 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:30 AM
AlloVir (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
10:51 AM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:55 AM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:56 AM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
12:17 PM
AlloVir (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
11:15 PM
AlloVir (Filer)
Form EFFECT
02/10/2025
3:19 PM
AlloVir (Filer)
Form 424B3
01/24/2025
1:51 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
1:55 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
2:03 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
AI Meltdown Imminent: Dump These Stocks Now! (Ad)

If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.

Click here to see the details and learn how to prepare for the next AI revolution
01/15/2025
3:39 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:41 PM
AlloVir (Subject)
Form 425
01/13/2025
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
6:44 AM
AlloVir (Subject)
Form 425
01/10/2025
6:42 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:21 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:23 PM
AlloVir (Subject)
Form 425
12/11/2024
4:07 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:37 AM
AlloVir (Filer)
Form S-4
Registration statement under Securities Act of 1933  
12/06/2024
8:50 PM
AlloVir (Subject)
Form 425
12/06/2024
6:23 AM
AlloVir (Filer)
Form DEF 14A
11/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:05 PM
AlloVir (Subject)
Form 425
11/08/2024
3:06 PM
AlloVir (Subject)
Form 425
11/08/2024
3:09 PM
AlloVir (Subject)
Form 425
11/08/2024
3:10 PM
AlloVir (Subject)
Form 425
11/08/2024
7:26 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:33 AM
AlloVir (Subject)
Form 425
11/05/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Vladimir Lenin was right… (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.
10/03/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
10:14 AM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALVR) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners